BioCentury
ARTICLE | Clinical News

Cipro XR extended-release ciprofloxacin regulatory update

November 4, 2002 8:00 AM UTC

BAYG's Bayer Corp. business (West Haven, N.J.) submitted an NDA to the FDA for Cipro XR to treat complicated urinary tract infections (UTI) with once-daily dosing for 7-14 days. In March, BAYG submitt...